Litcius/Paper detail

Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme

Matthew Gawley, Lorna Almond, Senam Daniel, Sarah Lastakchi, Sharnjit Kaur, A. Detta, Garth Cruickshank, C. Ryan Miller, Shawn Hingtgen, Kevin Sheets, Christopher McConville

2020Journal of Controlled Release18 citationsDOIOpen Access PDF

Topics & Concepts

IrinotecanTemozolomideIn vivoMedicineGliomaPharmacologyDacarbazineCamptothecinPLGADrug deliveryDrugCancer researchCancerChemotherapySurgeryChemistryInternal medicineIn vitroBiologyOrganic chemistryBiotechnologyBiochemistryColorectal cancerGlioma Diagnosis and TreatmentNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics
Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme | Litcius